Published in J Intensive Care on January 07, 2015
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis. Int J Gen Med (2016) 0.82
How the Linker Connecting the Two Kringles Influences Activation and Conformational Plasticity of Prothrombin. J Biol Chem (2016) 0.82
Microparticles as Biomarkers of Blood Coagulation in Cancer. Biomark Cancer (2015) 0.77
Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation. BBA Clin (2015) 0.76
Lectin-Based Characterization of Vascular Cell Microparticle Glycocalyx. PLoS One (2015) 0.75
High intravascular tissue factor-but not extracellular microvesicles-in septic patients is associated with a high SAPS II score. J Intensive Care (2016) 0.75
Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema. Blood Coagul Fibrinolysis (2015) 0.75
Analysis of Extracellular Vesicles Using Magnetic Nanoparticles in Blood of Patients with Acute Coronary Syndrome. Biochemistry (Mosc) (2016) 0.75
Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection. Medicine (Baltimore) (2016) 0.75
Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners. Arq Bras Cardiol (2017) 0.75
The signature of circulating microparticles in heart failure patients with metabolic syndrome. J Circ Biomark (2016) 0.75
New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer. Lung Cancer (Auckl) (2017) 0.75
Effects of intravitreally injected Fc fragment on rat eyes. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Endothelial vascular markers in coronary surgery. Heart Vessels (2017) 0.75
The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles. PLoS Biol (2017) 0.75
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Disseminated intravascular coagulation. N Engl J Med (1999) 5.49
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood (2007) 4.73
Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood (2005) 3.85
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 3.24
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest (1999) 3.19
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer (2005) 3.19
High-mobility group box 1 and cancer. Biochim Biophys Acta (2010) 3.11
Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med (2000) 3.10
Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost (2006) 3.03
Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res (2005) 2.97
Structure of the HMG box motif in the B-domain of HMG1. EMBO J (1993) 2.84
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood (2000) 2.51
Cellular microparticles: what are they bad or good for? J Thromb Haemost (2003) 2.41
Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood (2004) 2.41
Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost (2001) 2.38
Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost (2007) 2.34
Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost (2008) 2.24
Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol (2006) 2.23
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J (2010) 2.12
Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost (2010) 2.12
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta (2009) 2.07
Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost (2009) 2.05
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology (2005) 2.00
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol (2005) 1.96
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost (2004) 1.96
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood (2006) 1.95
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation (2001) 1.86
High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J (2003) 1.79
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol (2007) 1.72
Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost (2001) 1.65
Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol (2002) 1.64
Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 1.63
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes (2002) 1.61
Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med (2013) 1.56
Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost (2005) 1.55
Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost (2013) 1.53
Plasma microparticles and vascular disorders. Br J Haematol (2007) 1.52
High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood (1996) 1.50
Endothelial cell activation by leukocyte microparticles. J Immunol (1998) 1.49
Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens (2006) 1.45
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Thromb Haemost (2006) 1.43
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol (2005) 1.43
The platelet microparticle proteome. J Proteome Res (2005) 1.42
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int (2006) 1.37
Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood (2002) 1.37
Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol (2001) 1.35
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med (2009) 1.35
The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program (2011) 1.34
Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med (2007) 1.34
High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis (2001) 1.30
Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis (1999) 1.29
New players in haemostasis and thrombosis. Thromb Haemost (2014) 1.29
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost (2006) 1.29
Platelet microparticles induce angiogenesis in vitro. Br J Haematol (2004) 1.28
Function and role of microparticles in various clinical settings. Thromb Res (2008) 1.28
Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood (2006) 1.28
Leukocyte-derived microparticles in vascular homeostasis. Circ Res (2012) 1.28
Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol (2000) 1.26
Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost (2006) 1.25
Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol (2006) 1.24
Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol (1997) 1.21
Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem (1999) 1.21
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20
The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med (2014) 1.17
Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood (1999) 1.16
Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol (2004) 1.14
Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion (2006) 1.13
In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension (2007) 1.12
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost (2008) 1.12
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost (2007) 1.12
Formation and fate of platelet microparticles. Blood Cells Mol Dis (2006) 1.10
Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost (2003) 1.09
Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood (2004) 1.09
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res (2008) 1.04
Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost (2003) 1.02
Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis (2007) 1.01
Mechanisms of cellular activation by platelet microparticles. Thromb Haemost (1999) 1.00
Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost (2005) 1.00
Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. J Heart Lung Transplant (2008) 0.99
Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Cancer Res (2006) 0.99
Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer (2003) 0.98
Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol (2006) 0.97
Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost (2007) 0.96
Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome. Thromb Haemost (2004) 0.96
Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry (2000) 0.96
Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost (2005) 0.95
Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett (2006) 0.95
Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J (1998) 0.93
Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta (1992) 0.93
Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis (2006) 0.93
Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/ progenitor cells--implication for the pathogenesis of immune thrombocytopenias. Folia Histochem Cytobiol (2007) 0.92
Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res (1996) 0.92
Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity (2001) 0.92
Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost (2004) 0.92